Framework for a systems approach to proteomic biomarker profiling in polycystic ovary syndrome

Expert Review of Proteomics

Volumn 6, Issue 5, 2009, Pages 469-499

  Atiomo, William U ^a   Khalid, Somia ^b   Ziauddin, Aysha ^c   Tooth, David ^b   Layfield, Robert ^b  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^b UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^c NOTTINGHAM CITY HOSPITAL   (United Kingdom)

Author keywords

Database; Function; Pathway; Polycystic ovary syndrome; Proteomics; Systems biology

Indexed keywords

ALBUMIN; ALPHA ENOLASE; ALPHA1 GLYCOPROTEIN; APOLIPOPROTEIN A1; BETA ACTIN; BETA CENTRACTIN; BINDING PROTEIN; BIOLOGICAL MARKER; CATHEPSIN D; COFILIN 1; COLLAGEN; CYTOKERATIN; CYTOSOL AMINOPEPTIDASE; FASCIN; FIBRINOGEN; GLUTATHIONE TRANSFERASE M3; HEAT SHOCK PROTEIN 10; HEAT SHOCK PROTEIN 27; KININOGEN; LIPOCORTIN 11; LIPOCORTIN 2; LIPOCORTIN 5; PEROXIREDOXIN 2; PROTEIN DISULFIDE ISOMERASE; PROTEIN PRECURSOR; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE (UBIQUINONE); STROMAL CELL DERIVED FACTOR 20; TRANSGELIN; TRIOSEPHOSPHATE ISOMERASE; UNCLASSIFIED DRUG; URIDINE DIPHOSPHATE GLUCOSE DEHYDROGENASE;

ANTIOXIDANT ACTIVITY; ARTICLE; FIBRINOLYSIS; FUNCTIONAL PROTEOMICS; HUMAN; OVARY POLYCYSTIC DISEASE; PROTEIN DATABASE; PROTEIN FUNCTION; THROMBOSIS;

BIOLOGICAL MARKERS; FEMALE; HUMANS; POLYCYSTIC OVARY SYNDROME; PROTEOMICS; SYSTEMS BIOLOGY;

EID: 70350443223     PISSN: 14789450     EISSN: 17448387     Source Type: Journal    
DOI: 10.1586/epr.09.68     Document Type: Article

References (32)

1. Hardiman P, Pillay OC, Atiomo W. Polycystic ovary syndrome and endometrial carcinoma. Lancet 361(9371), 1810-1812 (2003).
2. Atiomo W, Pearson S, Shaw S, Prentice AG, Dubbins P. Ultrasound criteria in the diagnosis of polycystic ovary syndrome. Ultrasound Med. Biol. 26(6), 977-980 (2000).
3. Rotterdam ESHRE/ASRM-sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to PCOS. Hum. Reprod. 19(1), 41-47 (2004). • Background considerations in this consensus workshop agreeing the new diagnostic criteria for polycystic ovary syndrome (PCOS) highlight the challenges of diagnosis and demonstrate the need for proteomics.
4. Zhao SY, Qiao J, Li MZ et al. Discovery of distinct protein profiles for polycystic ovary syndrome with and without insulin resistance by surface-enhanced laser adsorption/ionization time of flight mass spectrometry. Fertil. Steril. 88(1), 145-151 (2007). (Pubitemid 47007689)
5. Atiomo W, El-Mahdi E, Hardiman P. Familial Associations in PCOS. Fertil. Steril. 80(1), 143-145 (2003).
6. Mathur R, Alexander CJ, Yano J, Trivax B, Azziz R Use of metformin in polycystic ovary syndrome. Am. J. Obstet. Gynecol. 199(6), 596-609 (2008).
7. Lorenz LB, Wild RA. Polycystic ovarian syndrome: an evidence-based approach to evaluation and management of diabetes and cardiovascular risks for today's clinician. Clin. Obstet. Gynecol. 50(1), 226-243 (2007).
8. Lujan ME, Chizen DR, Pierson RA. Diagnostic criteria for polycystic ovary syndrome: pitfalls and controversies. J. Obstet. Gynaecol. Can. 30(8), 671-679 (2008).
9. Hughes C, Elgasim M, Layfield R, Atiomo W. Genomic and post-genomic approaches to polycystic ovary syndrome - progress so far: mini review. Hum. Reprod. 21(11), 2766-2775 (2006). (Pubitemid 44566986)
10. Atiomo W, Khalid S, Parameshweran S, Houda M, Layfield R. Proteomic biomarkers for the diagnosis and risk stratification of polycystic ovary syndrome (PCOS): a systematic review. BJOG 116(2), 137-143 (2009). •• In total, 148 biomarkers were identified from six original studies on proteomics in PCOS.
11. Borro M, Gentile G, Stigliano A et al. Proteomic analysis of peripheral T lymphocytes, suitable circulating biosensors of strictly related diseases Clin. Exp. Immunol. 150, 494-501 (2007). (Pubitemid 350098726)
12. Choi, BC, Kim YS, Kim MS et al. Identification of overexpressed proteins by proteomic analysis using human follicular fluids derived from polycystic ovary syndrome (PCOS) patients. Fertil. Steril. 88, S180-S180 (2007).
13. Corton M, Botella-Carretero JI, Lopez, JA et al. Proteomic analysis of human omental adipose tissue in the polycystic ovary syndrome using two-dimensional difference gel electrophoresis and mass spectrometry. Hum. Reprod. 23 (3), 651-661(2008). (Pubitemid 351651200)
14. Ma X, Fan L, Meng Y et al. Proteomic analysis of human ovaries from normal and polycystic ovarian syndrome. Mol. Hum. Reprod. 13 (8), 527-535 (2007). • First study of proteomic biomarkers from the human ovary. A total of 70 biomarkers were identified. (Pubitemid 47241906)
15. Matharoo-Ball B, Hughes C, Lancashire L et al. characterization of biomarkers in pcos using multiple distinct proteomic platforms. J. Proteome Res. 6(8), 3321-3328 (2007). • Proteomic biomarkers associated with the complement system and haptoglobin were identified in serum from women with PCOS for the first time.
16. Zhao SY, Qiao J, Li MZ et al. Discovery of distinct protein profiles for polycystic ovary syndrome with and without insulin resistance by surface-enhanced laser adsorption/ionization time of flight mass spectrometry. Fertil. Steril. 88(1), 145-151 (2007). • Novel serum proteomic biomarkers identified based on their mass-to-charge values in women with PCOS. (Pubitemid 47007689)
17. Atiomo WU, Bates SA, Condon J, Shaw S, West JH, Prentice AG. The plasminogen activator system in women with the polycystic ovary syndrome. Fertil. Steril. 69, 236-241 (1998). (Pubitemid 28117100)
18. Atiomo W, Hilton D, Fox R et al. Immunohistochemical detection of plasminogen activator inhibitor-1 in polycystic ovaries. Gynecol. Endocrinol. 14(3), 162-168 (2000). (Pubitemid 30449892)
19. Liu YX, Liu K, Feng Q et al. Tissue-type plasminogen activator and its inhibitor plasminogen activator inhibitor type 1 are coordinately expressed during ovulation in the rhesus monkey. Endocrinology 145(4), 1767-1775 (2004). (Pubitemid 38402385)
20. Karakurt F, Gumus II, Bavbek N et al. Increased thrombin-activatable fibrinolysis inhibitor antigen levels as a clue for prothrombotic state in polycystic ovary syndrome. Gynecol. Endocrinol. 24(9), 491-497 (2008).
21. Hajjar KA, Jacovina AT, Chacko J. An endothelial cell receptor for plasminogen/tissue plasminogen activator. I. Identity with annexin II. J. Biol. Chem. 269(33), 21191-21197 (1994). (Pubitemid 24978790)
22. Ruan X, Dai Y. Study on chronic low-grade inflammation and influential factors of polycystic ovary syndrome. Med. Princ. Pract. 18(2), 118-122 (2009).
23. Wu Y, Zhang J, Wen Y, Wang H, Zhang M, Cianflone K. Increased acylation-stimulating protein, C-reactive protein, and lipid levels in young women with polycystic ovary syndrome. Fertil. Steril. 91(1), 213-219 (2009).
24. Bobe J, Nguyen T, Fostier A. Ovarian function of the trout preovulatory ovary: new insights from recent gene expression studies. Comp. Biochem. Physiol. A Mol. Integr. Physio. 153(1), 63-68 (2009).
25. Modugno F, Ness RB, Chen C, Weiss NS. Inflammation and endometrial cancer: a hypothesis Cancer Epidemiol. Biomarkers Pre. 14(12), 2840-2847 (2005). (Pubitemid 43068813)
26. Escobar-Morreale H, Insenser M, Corton M, San Millan JL, Peral B. Proteomics and genomics: a hypothesis-free approach to the study of the role of visceral adiposity in the pathogenesis of the polycystic ovary syndrome. Proteomics Clin. Appl. 2, 444-455 (2008).
27. Fenkci V, Fenkci S, Yilmazer M, Serteser M. Decreased total antioxidant status and increase oxidative stress in women with polycystic ovary syndrome may contribute to the risk of cardiovascular disease. Fertil. Steril. 80(1), 123-127 (2003). (Pubitemid 36808867)
28. Sabuncu T, Vural H, Harma M, Harma M. Oxidative stress in polycystic ovary syndrome and its contribution to the risk of cardiovascular disease. Clin. Biochem. 34(5), 407-413 (2001). (Pubitemid 32777851)
29. Cortón M, Botella-Carretero JI, Benguría A et al. Differential gene expression profile in omental adipose tissue in women with polycystic ovary syndrome. J. Clin. Endocrinol. Metab. 92(1), 328-337 (2007). (Pubitemid 46075011)
30. Lynn DJ, Winsor GL, Chan C et al. InnateDB: facilitating systems-level analyses of the mammalian innate immune response. Mol. Syst. Biol. 4, 218 (2008). •• Database providing a useful example of how future proteomic data arising from PCOS studies might be collated.
31. Universal Protein Resource Database. UniProt knowledgebase www.uniprot.org
32. InnateDB. A knowledge resource for innate immunity interactions and pathways www.innatedb.ca